Jim Simons Nuvation Bio Inc. Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 566,800 shares of NUVB stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

566,800

Previous 1,029,000 44.92%

Holding current value

$1.29 Million

Previous $2.37 Million 36.31%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$2.01 - $3.01 $929,021 - $1.39 Million	-462,200 Reduced 44.92%	566,800 $1.51 Million
Q3 2024 Nov 13, 2024	BUY	$2.3 - $3.83 $616,400 - $1.03 Million	268,000 Added 35.22%	1,029,000 $2.37 Million
Q2 2024 Aug 09, 2024	SELL	$2.58 - $3.69 $551,346 - $788,553	-213,700 Reduced 21.92%	761,000 $2.22 Million
Q1 2024 May 13, 2024	SELL	$1.46 - $3.97 $742,309 - $2.02 Million	-508,431 Reduced 34.28%	974,700 $3.55 Million
Q4 2023 Feb 13, 2024	BUY	$0.96 - $1.53 $1.05 Million - $1.67 Million	1,093,131 Added 280.29%	1,483,131 $2.24 Million
Q3 2023 Nov 14, 2023	BUY	$1.26 - $2.1 $98,406 - $164,010	78,100 Added 25.04%	390,000 $523,000
Q2 2023 Aug 11, 2023	BUY	$1.56 - $1.84 $60,528 - $71,392	38,800 Added 14.21%	311,900 $561,000
Q1 2023 May 12, 2023	BUY	$1.6 - $2.48 $206,240 - $319,672	128,900 Added 89.39%	273,100 $453,000
Q4 2022 Feb 13, 2023	SELL	$1.68 - $2.5 $195,409 - $290,787	-116,315 Reduced 44.65%	144,200 $277,000
Q3 2022 Nov 14, 2022	BUY	$0.29 - $4.04 $50,522 - $703,828	174,215 Added 201.87%	260,515 $584,000
Q2 2022 Aug 12, 2022	SELL	$3.24 - $5.85 $19,116 - $34,515	-5,900 Reduced 6.4%	86,300 $280,000
Q1 2022 May 13, 2022	BUY	$4.6 - $8.83 $195,959 - $376,158	42,600 Added 85.89%	92,200 $485,000
Q4 2021 Feb 11, 2022	SELL	$7.75 - $10.05 $6,200 - $8,040	-800 Reduced 1.59%	49,600 $422,000
Q3 2021 Nov 12, 2021	SELL	$7.78 - $10.0 $3.24 Million - $4.16 Million	-416,400 Reduced 89.2%	50,400 $501,000
Q2 2021 Aug 13, 2021	BUY	$9.22 - $14.48 $4.3 Million - $6.76 Million	466,800 New	466,800 $4.35 Million

Others Institutions Holding NUVB

# of Institutions

168

Shares Held

146M

Call Options Held

3.2K

Put Options Held

98.7K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $493M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account